Navigation Links
BRAF inhibitor treatment causes melanoma cells to shift how they produce energy
Date:3/8/2013

A multi-institutional study has revealed that BRAF-positive metastatic malignant melanomas develop resistance to treatment with drugs targeting the BRAF/MEK growth pathway through a major change in metabolism. The findings, which will be published in Cancer Cell and have been released online, suggest a strategy to improve the effectiveness of currently available targeted therapies.

"We were surprised to find that melanoma cells treated with the BRAF inhibitor vemurafenib dramatically change the way they produce energy to stay alive," says David E. Fisher, MD, PhD, chief of Dermatology at Massachusetts General Hospital (MGH) and a co-corresponding author of the Cancer Cell paper. "While current BRAF inhibitor treatment is a major improvement shrinking tumors in most patients and extending survival for several months patients eventually relapse. So there is an ongoing need to improve both the magnitude and durability of these responses."

In about half the cases of malignant melanoma the most deadly form of skin cancer tumor growth is driven by mutations in the BRAF gene. Research by investigators at the MGH Cancer Center and elsewhere has shown that treatment with drugs that block BRAF activity temporarily halts tumor growth. Combining a BRAF inhibitor with a drug that targets MEK, another protein in the same growth pathway, strengthens and extends the antitumor response. The current study was designed to investigate how BRAF inhibition changes metabolic activity within melanoma cells and to find other possible treatment targets.

The most common way that cells convert glucose into energy is called oxidative phosphorylation and largely relies on the activity of the cellular structures called mitochondria. Many cancer cells use an alternative mechanism that produces the energy compound ATP without involving mitochondria. A series of experiments by the MGH team revealed that the elevated BRAF activity in BRAF-positive m
'/>"/>

Contact: Michelle Marcella
mmarcella@partners.org
617-724-2755
Massachusetts General Hospital
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy
2. VyGone Inhibitor Zapper: The Brand New Solution For the Safe Treatment Of Sores, Warts and Herpes
3. Inhibitors of shuttle molecule show promise in acute leukemia
4. Leukemia inhibitory factor may be a promising target against pancreatic cancer
5. Uncommon BRAF mutation in melanoma sensitive to MEK inhibitor drug therapy
6. Preclinical data support ongoing clinical trials testing IDO inhibitors as a treatment for cancer
7. PARP inhibitors may have clinical utility in HER2-positive breast cancers
8. New mechanism of action for PARP inhibitors discovered
9. PI3-kinase and PARP inhibitor combo may offer new treatment option for triple-neg breast cancers
10. Scientists at Mainz University identify inhibitor of myelin formation in the central nervous system
11. New small molecule inhibitor could be a safe and first-line treatment for metastatic breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... (PRWEB) April 01, 2015 Aging2.0 ... care, today announces the launch of the Aging2.0 ... senior care stakeholders and technology companies. The announcement was ... (NIC) Capital and Business Strategies Forum in San ... the new Alliance program is now open for additional ...
(Date:4/1/2015)... 01, 2015 When annoying or concerning ... days or weeks for an appointment with a dermatologist ... next day appointments haven’t been possible within dermatology. However, ... offices have noticed demand for this level of service ... how important relief or answers to dermatological issues are ...
(Date:4/1/2015)... Wayne, PA (PRWEB) April 01, 2015 ... critical points in the talent lifecycle, and the premiere ... Hiring Expert Series will feature a webinar on “Using ... presented by the chief human resources officer of MorseLife, ... support services for seniors and their families in Palm ...
(Date:4/1/2015)... April 01, 2015 Franklin University, one ... to announce the establishment of the Greta J. Russell ... made possible through the generous gift of $100,000 from ... on behalf of Medical Mutual to University representatives, ... President of Advancement & Strategic Relations. , “We ...
(Date:4/1/2015)... Doctors in Italy have just published research ... against mesothelioma at higher doses. Surviving Mesothelioma has just ... Click here to read it now. , The ... of Siena with unresectable advanced mesothelioma whose ... patients received monthly doses of tremelimumab (instead of every ...
Breaking Medicine News(10 mins):Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 2Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 3Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 4Health News:Dermatology Associates of Wisconsin and Forefront Dermatology Answers Patients' Needs With Unmatched Availability In Sheboygan and Sheboygan Falls 2Health News:SkillSurvey Hiring Expert Series Continues with Webinar Featuring MorseLife 2Health News:SkillSurvey Hiring Expert Series Continues with Webinar Featuring MorseLife 3Health News:Franklin University Receives Gift to Create the Greta J. Russell Medical Mutual of Ohio Scholarship 2Health News:Franklin University Receives Gift to Create the Greta J. Russell Medical Mutual of Ohio Scholarship 3Health News:New Research Finds Immunotherapy Drug May Fight Mesothelioma Better at Higher Doses, According to Surviving Mesothelioma 2
... of Stonewall Award, BOSTON, June 4 On ... lighting, presented by Citibank, will,run from 7-9 p.m. outside ... (BCA) on Tremont Street in Boston,s South End., ... feature appearances by Bravo TV,s "Top Chef" winners Jen ...
... the time a mother nurses doesn,t protect the baby, ... Each year, an estimated 200,000 babies worldwide are infected ... Now, a new study suggests that a short-term drug ... "It is very practical, and these drugs are relatively ...
... of progress among Hispanic children , , WEDNESDAY, June 4 ... likely to engage in risky health behaviors, including sexual ... teens, U.S. health officials said Wednesday. , While there ... school students, Hispanic students remain at higher risk for ...
... Marks Healthcare Partners LLC provides performance improvement and ... turnaround for the healthcare industry, ... announces the,addition of Carl Marks Healthcare Partners LLC (CMHP) to ... performance,improvement and turnaround management for the healthcare industry., "Carl ...
... 4 Walgreen Co. of,Deerfield, Ill., has agreed ... from,2001 to 2005, it improperly switched patients to ... Eldepryl in order to,increase its reimbursement from Medicaid, ... over 5,000 retail pharmacies throughout the,U.S., switched the ...
... DTC Perspectives, Inc. is,proud to introduce the first DTC ... recognize individuals who have made significant contributions to,advancing the ... extraordinary achievement in DTC marketing., To inaugurate the ... individuals,will be inducted and announced. The official Hall of ...
Cached Medicine News:Health News:Fifteenth Annual Pridelights Goes Green 2Health News:Drug Regimen Prevents AIDS Transmission Via Breast Milk 2Health News:Drug Regimen Prevents AIDS Transmission Via Breast Milk 3Health News:Fewer U.S. High School Students Engage in Risky Behaviors 2Health News:Fewer U.S. High School Students Engage in Risky Behaviors 3Health News:Carl Marks Establishes New Healthcare Business Unit 2Health News:Walgreens to Pay $35 Million to U.S., 46 States & Puerto Rico to Settle Medicaid Prescription Drug Fraud Allegations 2Health News:DTC Perspectives, Inc. Announces the New DTC Hall of Fame Award 2
(Date:4/1/2015)... 2015   Advocates for Responsible Care , a ... care professionals, patient advocates and human rights specialists, today ... go live at 9:00 a.m. today. Logo ... is a new campaign to limit rising out-of-pocket costs ... Advocates for Responsible Care, in partnership with the Specialty ...
(Date:4/1/2015)... , April 1, 2015  Chiltern, a leading ... the 2015 CenterWatch survey of 1,900 global investigative sites. ... Romberg , Vice President of Global Clinical Development noted, ... the all the clinical trial investigators we are privileged ... having a deep understanding of the patient experience and ...
(Date:4/1/2015)... , April 1, 2015   AMC Health ... will showcase advances in monitored care that are transforming ... HIMSS 2015 Conference. The conference will be ... , from April 12 through 16. In addition to ... respective booths, AMC Health will share innovations that transform ...
Breaking Medicine Technology:'Rx in Reach' Campaign Launches in Georgia 2'Rx in Reach' Campaign Launches in Georgia 3Chiltern Ranks Among Top CROs In Global Survey Of Clinical Research Sites 2AMC Health Demonstrates Advances in Monitored Care at HIMSS 2015 2AMC Health Demonstrates Advances in Monitored Care at HIMSS 2015 3AMC Health Demonstrates Advances in Monitored Care at HIMSS 2015 4
OCD-3000 pnuematic conserving regulator....
OCD-2000 electronic conserving regulator....
The 24-Hour Oxygen Conserver....
Lightweight Pneumatic Conserver., ,NOTE: All models passed the ASTM PS 127-00 regulator ignition safety test....
Medicine Products: